Clinical Trials Logo

Clinical Trial Summary

This study evaluates the efficacy of an accelerated schedule of theta-burst stimulation for treating manic episodes in bipolar disorder. In this open-label study, all participants will receive accelerated theta-burst stimulation.


Clinical Trial Description

Repetitive transcranial magnetic stimulation (rTMS) is an established technology as therapy for treatment-resistant depression. The approved method for treatment is 10Hz stimulation for 40 minutes over the left dorsolateral prefrontal cortex (L-DLPFC). This methodology has been very successful in real-world situations. The limitations of this approach include the duration of the treatment (approximately 40 minutes per treatment session over 4-6 weeks). Recently, researchers have modified the treatment parameters to reduce treatment times with some preliminary success. In a recent study, an accelerated paradigm showed a significant antidepressant effect (90% remission rate) in individuals with treatment-resistant depression (TRD), in only 5 days. Additionally, 5 participants from this study carried a bipolar diagnosis and responded similarly, with no adverse events experienced or manic/hypomanic conversion observed during the treatment series. In parallel to this, evidence in the literature shows that right prefrontal rapid TMS is safe and efficacious in the treatment of bipolar mania showing laterality opposed to the proposed effect of rapid TMS in depression. The current trial intends to utilise this modified design, i.e., an accelerated theta burst stimulation treatment over the right prefrontal cortex, for manic episodes in bipolar disorder. The trial also aims to look at the change in clinical measures and neuroimaging biomarkers. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04058249
Study type Interventional
Source Stanford University
Contact
Status Terminated
Phase N/A
Start date November 1, 2019
Completion date December 20, 2021

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04358900 - Unobtrusive Monitoring of Affective Symptoms and Cognition Using Keyboard Dynamics (UnMASCK)
Recruiting NCT05870501 - Synaptic Imaging and Network Activity in Treatment Resistant Depression N/A
Recruiting NCT01879982 - PSYCHE (Personalised Monitoring SYstems for Care in Mental Health) N/A
Completed NCT05683431 - Using Neuroplasticity-Based Computerized Training to Improve Emotion Regulation in Bipolar Disorder (BRAINS) N/A
Recruiting NCT05934474 - Biocollection on Peripheral Inflammation
Completed NCT03822416 - Treating Smokers With Mental Illness Phase 2
Recruiting NCT05878730 - Melatonin and Response to Lithium
Not yet recruiting NCT05705063 - Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar Illness N/A
Completed NCT02642029 - Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study N/A
Not yet recruiting NCT04168697 - Effect of Behavioral Intervention on Cannabinoid Receptors in BAD N/A
Recruiting NCT05025605 - Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder Phase 1
Completed NCT03692910 - A Study to Evaluate SAGE-217 in Participants With Bipolar I/II Disorder With a Current Major Depressive Episode Phase 2
Active, not recruiting NCT04812379 - Specified Drug-use Survey on Abilify Prolonged Release Aqueous Suspension for IM Injection (Prevention of Relapse of Mood Episodes in BP)
Not yet recruiting NCT06107764 - Cerebellar Modulation of Cognition in Psychosis N/A